Vision
A world where genomic insights accelerate global progress
About
Who We Are
Theiagen is a data analysis company staffed by Next Generation Sequencing (NGS) and public health experts, committed to improving infectious disease control, food safety, molecular diagnostics, and environmental monitoring.
Our academic, governmental, and industry expertise contributes knowledge from a diverse range of projects including infectious disease surveillance, cancer research, biofuel developments, and microbial strain engineering. Hence, we bring unparalleled expertise to your table, allowing you to benefit from decades in the field.
Mission
To harness the full potential of genomics
What We Believe
Genome sequencing technologies used to be the domain of large academic institutions or governmental research groups. However, we believe in the democratization of technical expertise through collaborative knowledge sharing, workflow support, and world-leading data analysis services.
This democratization can allow any clinical, environmental, or food safety organization to achieve their strategic and scientific goals, regardless of their size and resource availability.
We believe that achieving results should be quicker, more affordable, and have higher resolution and accuracy than ever before.
Our Team
Joel R. Sevinsky
CEO/Founder
Ph.D. in Molecular, Cellular, and Developmental
Biology from CU Boulder
BA in Microbiology from UC Santa Barbara
Dr. Sevinsky has leveraged over two decades of experience in systems biology and has taken aim at transforming public health and infectious disease surveillance through innovative implementation of NGS and bioinformatics technologies. During a three-year tenure at the Colorado Department of Public Health and Environment, he led several initiatives to build NGS testing and bioinformatics capacity at the state, regional, and national levels.
In 2019 Dr. Sevinsky’s ambitions to impact public health exceeded his role as a government scientist, resulting in the formation of Theiagen Genomics. Dr. Sevinsky and his team now work with over four dozen public health laboratories nationally and more than a dozen internationally across Africa and Asia.
Joel R. Sevinsky
CEO/Founder
Ph.D. in Molecular, Cellular, and Developmental
Biology from CU Boulder
BA in Microbiology from UC Santa Barbara
Dr. Sevinsky has leveraged over two decades of experience in systems biology and has taken aim at transforming public health and infectious disease surveillance through innovative implementation of NGS and bioinformatics technologies. During a three-year tenure at the Colorado Department of Public Health and Environment, he led several initiatives to build NGS testing and bioinformatics capacity at the state, regional, and national levels.
In 2019 Dr. Sevinsky’s ambitions to impact public health exceeded his role as a government scientist, resulting in the formation of Theiagen Genomics. Dr. Sevinsky and his team now work with over four dozen public health laboratories nationally and more than a dozen internationally across Africa and Asia.
x
Kevin G. Libuit
VP of Operations
MS and BA in Biology from James Madison University
Kevin Libuit is a dedicated scientist and operations leader committed to advancing the integration of DNA sequencing and bioinformatics technologies to strengthen critical decision-making.
As Vice President of Operations at Theiagen Genomics, Kevin leads day-to-day operations, resource management, and team coordination to ensure projects are aligned with company goals and deliver exceptional outcomes that meet our partners’ needs. He excels at translating high-level strategies into actionable plans, optimizing processes, and fostering seamless collaboration across teams and initiatives. His operational oversight has contributed to the adoption of Theiagen’s open-source solutions by over 90 public health, academic, and industry partners across more than 40 countries worldwide.
Kevin’s expertise in microbial bioinformatics and public health provides a strong foundation for his work. He is a co-founder of the State Public Health Bioinformatics (StaPH-B) consortium and a former Chair of the Public Health Alliance for Genomic Epidemiology’s (PHA4GE) Bioinformatics Working Group. Before joining Theiagen, he served as the Bioinformatics Lead Scientist for the Commonwealth of Virginia, where he developed and implemented bioinformatics solutions for public health laboratories across the Mid-Atlantic Region.
Kevin’s ability to unite technical expertise with operational excellence has established him as a leader in microbial bioinformatics and a champion of impactful, multi-disciplinary innovation.
Kevin G. Libuit
VP of Operations
MS and BA in Biology from James Madison University
Kevin Libuit is a dedicated scientist and operations leader committed to advancing the integration of DNA sequencing and bioinformatics technologies to strengthen critical decision-making.
As Vice President of Operations at Theiagen Genomics, Kevin leads day-to-day operations, resource management, and team coordination to ensure projects are aligned with company goals and deliver exceptional outcomes that meet our partners’ needs. He excels at translating high-level strategies into actionable plans, optimizing processes, and fostering seamless collaboration across teams and initiatives. His operational oversight has contributed to the adoption of Theiagen’s open-source solutions by over 90 public health, academic, and industry partners across more than 40 countries worldwide.
Kevin’s expertise in microbial bioinformatics and public health provides a strong foundation for his work. He is a co-founder of the State Public Health Bioinformatics (StaPH-B) consortium and a former Chair of the Public Health Alliance for Genomic Epidemiology’s (PHA4GE) Bioinformatics Working Group. Before joining Theiagen, he served as the Bioinformatics Lead Scientist for the Commonwealth of Virginia, where he developed and implemented bioinformatics solutions for public health laboratories across the Mid-Atlantic Region.
Kevin’s ability to unite technical expertise with operational excellence has established him as a leader in microbial bioinformatics and a champion of impactful, multi-disciplinary innovation.
x
Andrew J. Page
Director of Technical Innovation
Ph.D. in Computer Science and BSc in Computer Science and Software Engineering from National University of Ireland Maynooth
Prof. Andrew Page has over 15 years of experience in bioinformatics, specializing in infectious disease bioinformatics, next-generation sequencing, and machine learning. His Ph.D. studies in machine learning and distributed computing have informed his approach to microbial bioinformatics, first at the Wellcome Sanger Institute in Cambridge, UK, and then as Head of Informatics at the Quadram Institute in Norwich, UK. Andrew has developed over 30 open-source tools, many of which are widely used in public health worldwide, such as Roary and Gubbins. He currently has over 150 peer-reviewed publications, spanning the fields of microbial genomics, bioinformatics, distributed computing, sequencing methods, and machine learning.
Andrew is a member of the Advisory Committee on the Microbiological Safety of Food, providing expert advice to the UK Government Food Standards Agency, and is a visiting professor at the University of East Anglia. During the COVID-19 pandemic, he led a SARS-CoV-2 sequencing and bioinformatics analysis lab, sequencing and analyzing over 80,000 genomes for the UK and 13 other countries with COG-UK.
Andrew co-hosts multiple podcasts: The MicroBinfie Podcast, The Bioinformatics Lab, and Research Pages, sharing expert knowledge on AI and bioinformatics with the world.
Andrew J. Page
Director of Technical Innovation
Ph.D. in Computer Science and BSc in Computer Science and Software Engineering from National University of Ireland Maynooth
Prof. Andrew Page has over 15 years of experience in bioinformatics, specializing in infectious disease bioinformatics, next-generation sequencing, and machine learning. His Ph.D. studies in machine learning and distributed computing have informed his approach to microbial bioinformatics, first at the Wellcome Sanger Institute in Cambridge, UK, and then as Head of Informatics at the Quadram Institute in Norwich, UK. Andrew has developed over 30 open-source tools, many of which are widely used in public health worldwide, such as Roary and Gubbins. He currently has over 150 peer-reviewed publications, spanning the fields of microbial genomics, bioinformatics, distributed computing, sequencing methods, and machine learning.
Andrew is a member of the Advisory Committee on the Microbiological Safety of Food, providing expert advice to the UK Government Food Standards Agency, and is a visiting professor at the University of East Anglia. During the COVID-19 pandemic, he led a SARS-CoV-2 sequencing and bioinformatics analysis lab, sequencing and analyzing over 80,000 genomes for the UK and 13 other countries with COG-UK.
Andrew co-hosts multiple podcasts: The MicroBinfie Podcast, The Bioinformatics Lab, and Research Pages, sharing expert knowledge on AI and bioinformatics with the world.
x
Gregory S. Legacki
Chief Operating Officer
B.S. in Economics Specialization in Accounting from Cornell University of Ithaca NY
Gregory S. Legacki is a business-minded professional with a passion for innovation and strategic leadership. His dynamic career, which spans pioneering start-ups to leading operations in large government organizations, has informed his exceptional ability to drive positive change and deliver results.
Gregory’s innovation mindset, which combines strong leadership skills with a unique balance of critical and creative thinking has led to the development of ground-breaking solutions that have redefined operational success in various organizations. He is passionate about creating value through excellence and is always eager to embrace new challenges and opportunities.
Gregory S. Legacki
Chief Operating Officer
B.S. in Economics Specialization in Accounting from Cornell University of Ithaca NY
Gregory S. Legacki is a business-minded professional with a passion for innovation and strategic leadership. His dynamic career, which spans pioneering start-ups to leading operations in large government organizations, has informed his exceptional ability to drive positive change and deliver results.
Gregory’s innovation mindset, which combines strong leadership skills with a unique balance of critical and creative thinking has led to the development of ground-breaking solutions that have redefined operational success in various organizations. He is passionate about creating value through excellence and is always eager to embrace new challenges and opportunities.
x
